These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 29995776

  • 1. Outcome of adult T-lymphoblastic lymphoma depends on ALL-type chemotherapy, prognostic factors, and performance of allogeneic hematopoietic stem cell transplantation.
    Hu M, Wang H, Wang L, Yang M, Lou Y, Jin J.
    Medicine (Baltimore); 2018 Jul; 97(28):e11374. PubMed ID: 29995776
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for T lymphoblastic leukemia/lymphoma].
    Luo L, Jiao Y, Yang P, Li Y, Huang WY, Ke XY, Zou DH, Jing HM.
    Zhonghua Xue Ye Xue Za Zhi; 2023 May 14; 44(5):388-394. PubMed ID: 37550188
    [Abstract] [Full Text] [Related]

  • 3. Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation.
    Jeong SH, Moon JH, Kim JS, Yang DH, Park Y, Cho SG, Kwak JY, Eom HS, Won JH, Hong JS, Oh SY, Lee HS, Kim SJ.
    Ann Hematol; 2015 Apr 14; 94(4):617-25. PubMed ID: 25465233
    [Abstract] [Full Text] [Related]

  • 4. Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
    Yasuda S, Najima Y, Konishi T, Yamada Y, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Shingai N, Yoshioka K, Inamoto K, Mukae J, Toya T, Igarashi A, Shimizu H, Kobayashi T, Kakihana K, Sakamaki H, Kawamata N, Ohashi K, Doki N.
    Leuk Res; 2021 Sep 14; 108():106627. PubMed ID: 34062327
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China.
    Luo L, Jiao Y, Li Y, Yang P, Gao J, Huang S, Huang W, Wang J, Dong F, Ke X, Zou D, Gao C, Jing H.
    Ann Hematol; 2024 Jun 14; 103(6):2073-2087. PubMed ID: 38581546
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Qin Y, Shi YK, He XH, Han XH, Zhou SY, Liu P, Yang JL, Yang S, Zhang CG, Dong M, Zhou LQ, Wang JW, Feng FY, Sun Y.
    Zhonghua Zhong Liu Za Zhi; 2009 Jun 14; 31(6):469-73. PubMed ID: 19950562
    [Abstract] [Full Text] [Related]

  • 7. Role of Allogeneic HCT as Postremission Therapy for Transplant-Eligible Adult Lymphoblastic Leukemia/Lymphoma After Frontline Hyper-CVAD.
    Damlaj M, Snnallah M, Bashir R, Eddine IS, Alahmari B, Salama H, Alaskar A, Alhejazi A, Alzahrani M.
    Clin Lymphoma Myeloma Leuk; 2020 Oct 14; 20(10):690-696. PubMed ID: 32636149
    [Abstract] [Full Text] [Related]

  • 8. [Characteristics and Prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma from Multicenter].
    Li ZH, Luo L, Yang P, Li Y, Zou DH, Gao CJ, Jing HM.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb 14; 32(1):120-124. PubMed ID: 38387909
    [Abstract] [Full Text] [Related]

  • 9. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma.
    Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM.
    Cancer; 2002 May 15; 94(10):2738-44. PubMed ID: 12173345
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
    Morita K, Jain N, Kantarjian H, Takahashi K, Fang H, Konopleva M, El Hussein S, Wang F, Short NJ, Maiti A, Sasaki K, Garcia-Manero G, Konoplev S, Ravandi F, Khoury JD, Jabbour E.
    Am J Hematol; 2021 May 01; 96(5):589-598. PubMed ID: 33639000
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ.
    Cancer; 2004 Dec 15; 101(12):2788-801. PubMed ID: 15481055
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of 18F-FDG PET/CT in T-Lymphoblastic lymphoma before and after hematopoietic stem cell transplantation.
    Sun N, Qiao W, Xing Y, Wang T, Yang J, Zhao J.
    Clin Transl Oncol; 2021 Aug 15; 23(8):1571-1576. PubMed ID: 33449269
    [Abstract] [Full Text] [Related]

  • 16. Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia.
    Bai L, Cheng YF, Lu AD, Suo P, Wang Y, Zuo YX, Yan CH, Wu J, Jia YP, Sun YQ, Chen YH, Chen H, Liu KY, Han W, Xu LP, Wang JB, Tang XF, Chen HR, Zhang LP, Huang XJ.
    Leuk Res; 2020 Apr 15; 91():106333. PubMed ID: 32109757
    [Abstract] [Full Text] [Related]

  • 17. The outcome of relapsed childhood acute lymphoblastic leukemia after allogeneic hematopoietic stem-cell transplantations: A single-center experience.
    Aygüneş U, Karagün BŞ, Şaşmaz I, Antmen AB.
    Clin Transplant; 2024 May 15; 38(5):e15366. PubMed ID: 38775798
    [Abstract] [Full Text] [Related]

  • 18. Effect of sustained measurable residue disease negativity and post-remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults.
    Yu J, Luo Y, Wang L, Wang T, Ye M, Chen J, Ni X, Chen L, Gao L, Yang J.
    Cancer Med; 2024 May 15; 13(10):e7310. PubMed ID: 38785213
    [Abstract] [Full Text] [Related]

  • 19. The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission.
    Wang L, Wang Y, Tang W, Dou HB, Shan JH, Hu J.
    Int J Hematol; 2013 Nov 15; 98(5):569-77. PubMed ID: 24078372
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.